A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation

Journal of Controlled Release

Volumn 110, Issue 2, 2006, Pages 290-295

  Lee, Dong Yun ^a   Park, Sang Jin ^b   Nam, Jong Hee ^c   Byun, Youngro ^a  

^a Seoul National University   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Combination therapy; Cyclosporine A; Pancreatic islet; PEGylation

Indexed keywords

BIOLOGICAL ORGANS; GLUCOSE; IMMUNOLOGY; LIVING SYSTEMS STUDIES; MEDICAL PROBLEMS; POLYETHYLENE GLYCOLS; TOXICITY; TRANSPLANTATION (SURGICAL);

COMBINATION THERAPY; CYCLOSPORINE A; PANCREATIC ISLET; PEGYLATION;

DRUG THERAPY;

CYCLOSPORIN A; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; MACROGOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL SURVIVAL; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; IMMUNITY; IMMUNOCOMPETENT CELL; KIDNEY; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; BLOOD GLUCOSE; CYCLOSPORINE; DIABETES MELLITUS, EXPERIMENTAL; EXCIPIENTS; GLUCOSE TOLERANCE TEST; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; NEPHRECTOMY; POLYETHYLENE GLYCOLS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES;

EID: 29244481989     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.10.023     Document Type: Article

References (18)

1. A.M.J. Shapiro, J.R.T. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, G.L. Warnock, N.M. Kneteman, and R.V. Rajotte Islet transplantation in seven patients with type I diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N. Engl. J. Med. 343 2000 230 238
2. E.A. Ryan, J.R.T. Lakey, R.V. Rajotte, G.S. Korbutt, T. Kin, S. Imes, A. Rabinovitch, J.F. Elliott, D. Bigam, N.M. Kneteman, G.L. Warnock, I. Larsen, and A.M.J. Shapiro Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol Diabetes 50 2001 710 719
3. C.R. Stiller The Canadian multicentre transplant study group: a randomized clinical trial of cyclosporine in cadaveric renal transplantation N. Engl. J. Med. 309 1983 809 815
4. E. Mahe, E. Morelon, S. Lechaton, K.H. Sang, R. Mansouri, M.F. Ducasse, M.F. Mamzer-Bruneel, Y. de Prost, H. Kreis, and C. Bodemer Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy Transplantation 79 2005 476 482
5. Y. Akar, G. Yucel, A. Durukan, I. Yucel, and G. Arici Systemic toxicity of tacrolimus given by various routes and the response to dose reduction Clin. Exp. Ophthalmol. 33 2005 53 59
6. R.C. Ayres, B. Dousset, S. Wixon, J.A. Buckels, P. McMaster, and A.D. Mayer Peripheral neurotoxicity with tacrolimus Lancet 343 1994 862 863
7. J.L. Panza, W.R. Wagner, H.L.R. Rilo, R.H. Rao, E.J. Beckman, and A.J. Russell Treatment of rat pancreatic islets with reactive PEG Biomaterials 21 2000 1155 1164
8. D.Y. Lee, K. Yang, S. Lee, S.Y. Chae, K.W. Kim, M.K. Lee, D.J. Han, and Y. Byun Optimization of monomethoxy-polyethylene glycol grafting on the pancreatic islet capsules J. Biomed. Mater. Res. 62 2002 372 377
9. D.Y. Lee, J.Y. Jang, S.J. Park, and Y. Byun Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets Biomaterials 25 2004 3663 3669
10. D.Y. Lee, J.H. Nam, and Y. Byun Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocytes and cytokine attacks J. Biomater. Sci., Polym. Ed. 15 2004 753 766
11. J.L. Contreras, D. Xie, J. Mays, C.A. Smyth, C. Eckstein, F.G. Rahemtulla, C.J. Young, J.A. Thompson, G. Bilbao, D.T. Curiel, and D.E. Eckhoff A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets Surgery 136 2004 537 547
12. D. Xie, C.A. Smyth, C. Eckstein, G. Bilbao, J. Mays, D.E. Eckhoff, and J.L. Contreras Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation Biomaterials 26 2005 403 412
13. M. Amiji, and K. Park Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity S.L. Cooper C.H. Bamford T. Tsuruta Polymer Biomaterials in Solution, as Interfaces and as Solids 1995 VSP Utrecht, The Netherlands 535 552
14. G. Hoofman, S. Herman, and E. Schacht Poly(ethylene glycol) with reactive end groups: I. Modification of proteins J. Bioact. Compat. Polym. 10 1995 145 187
15. D.Y. Lee, S.J. Park, J.H. Nam, Y. Byun, A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: long-functioning PEGylated islets in vivo, Tissue Eng. (in press).
16. A. Dibelius, H. Konigsberger, P. Walter, W. Permanetter, W. Brendel, and B.U. von Specht Prolonged reversal of diabetes in the rat by transplantation of allogeneic islets from a single donor and cyclosporine treatment Transplantation 41 1986 426 431
17. M. Gotoh, T. Maki, S. Satomi, J. Porter, and A.P. Monaco Immunological characteristics of purified pancreatic islet grafts Transplantation 42 1986 387 390
18. H.L. Bank Assessment of islets cell viability using fluorescent dyes Diabetologia 30 1987 812 816